The U.S. Food and Drug Administration today announced that it is requiring manufacturers of two prescription topical testosterone gel products, AndroGel 1 percent and Testim 1 percent, to include a boxed warning on the products’ labels.
Read the original here:
Testosterone Gel Safety Concerns Prompt FDA to Require Label Changes, Medication Guide